Form D · Other Health Care
Neuro42, Inc.
San Francisco, CA · CIK 0002026406
Offering snapshot reported Sep 16, 2024 · SEC filing
- Reported sold
- $15.6M Offering amount: $36.6M
- Investors reported
- 85 Form D · investor count
- Minimum accepted
- $1 Reported outside-investor minimum
- First sale
- Sep 4, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 16, 2024 | Initial | $15,551,687 | No comparison | 85 | SEC filing |
| Jun 11, 2024 | Initial | $6,655,181 | No comparison | 24 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-524089
$11,551,686.64 of the amount sold is from conversion of outstanding notes
Source: Form D, filed Sep 16, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Abhita Batra | Director, Executive |
| Krishna R. Bhupal | Director |
| Shibu Gangadharan | Executive |
| Rahul Talwar | Director |
| Amit Vohra | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
2 Bryant St Ste 240
San Francisco, CA, 94105
San Francisco, CA, 94105